153 related articles for article (PubMed ID: 26679809)
1. Promoter mutation and reduced expression of BRCA1 in canine mammary tumors.
Qiu HB; Sun WD; Yang X; Jiang QY; Chen S; Lin DG
Res Vet Sci; 2015 Dec; 103():143-8. PubMed ID: 26679809
[TBL] [Abstract][Full Text] [Related]
2. Relationship between three novel SNPs of BRCA1 and canine mammary tumors.
Sun W; Yang X; Qiu H; Zhang D; Wang H; Huang J; Lin D
J Vet Med Sci; 2015 Nov; 77(11):1541-3. PubMed ID: 26156012
[TBL] [Abstract][Full Text] [Related]
3. Roles of DNA mutation in the coding region and DNA methylation in the 5' flanking region of BRCA1 in canine mammary tumors.
Qiu H; Lin D
J Vet Med Sci; 2016 Jul; 78(6):943-9. PubMed ID: 26888582
[TBL] [Abstract][Full Text] [Related]
4. Expression patterns of the BRCA1 splicing variants in canine normal tissues and mammary gland tumors.
Sugiura T; Matsuyama S; Akiyosi H; Takenaka S; Yamate J; Kuwamura M; Aoki M; Shimada T; Ohashi F; Kubo K
J Vet Med Sci; 2007 Jun; 69(6):587-92. PubMed ID: 17611353
[TBL] [Abstract][Full Text] [Related]
5. Reduced canine BRCA2 expression levels in mammary gland tumors.
Yoshikawa Y; Morimatsu M; Ochiai K; Ishiguro-Oonuma T; Wada S; Orino K; Watanabe K
BMC Vet Res; 2015 Jul; 11():159. PubMed ID: 26202431
[TBL] [Abstract][Full Text] [Related]
6. Breed-related differences in altered BRCA1 expression, phenotype and subtype in malignant canine mammary tumors.
Im KS; Kim IH; Kim NH; Lim HY; Kim JH; Sur JH
Vet J; 2013 Mar; 195(3):366-72. PubMed ID: 22901454
[TBL] [Abstract][Full Text] [Related]
7. The combined expression pattern of BMP2, LTBP4, and DERL1 discriminates malignant from benign canine mammary tumors.
Klopfleisch R; Klose P; Gruber AD
Vet Pathol; 2010 May; 47(3):446-54. PubMed ID: 20375427
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of BRCA2 and RAD51 in lymph node metastases of canine mammary adenocarcinomas.
Klopfleisch R; Gruber AD
Vet Pathol; 2009 May; 46(3):416-22. PubMed ID: 19176491
[TBL] [Abstract][Full Text] [Related]
9. DNA Methylation Status of the Estrogen Receptor α Gene in Canine Mammary Tumors.
Brandão YO; Toledo MB; Chequin A; Cristo TG; Sousa RS; Ramos EAS; Klassen G
Vet Pathol; 2018 Jul; 55(4):510-516. PubMed ID: 29566609
[TBL] [Abstract][Full Text] [Related]
10. Mutations of p53 tumor suppressor gene in spontaneous canine mammary tumors.
Lee CH; Kweon OK
J Vet Sci; 2002 Dec; 3(4):321-5. PubMed ID: 12819382
[TBL] [Abstract][Full Text] [Related]
11. Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines.
Ahern TE; Bird RC; Bird AE; Wolfe LG
Am J Vet Res; 1996 May; 57(5):693-6. PubMed ID: 8723884
[TBL] [Abstract][Full Text] [Related]
12. p16INK4a suppresses BRCA1-deficient mammary tumorigenesis.
Scott A; Bai F; Chan HL; Liu S; Ma J; Slingerland JM; Robbins DJ; Capobianco AJ; Pei XH
Oncotarget; 2016 Dec; 7(51):84496-84507. PubMed ID: 27811360
[TBL] [Abstract][Full Text] [Related]
13. p53 gene mutations occurring in spontaneous benign and malignant mammary tumors of the dog.
Muto T; Wakui S; Takahashi H; Maekawa S; Masaoka T; Ushigome S; Furusato M
Vet Pathol; 2000 May; 37(3):248-53. PubMed ID: 10810989
[TBL] [Abstract][Full Text] [Related]
14. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
15. Expression patterns of the erbB subfamily mRNA in canine benign and malignant mammary tumors.
Matsuyama S; Nakamura M; Yonezawa K; Shimada T; Ohashi F; Takamori Y; Kubo K
J Vet Med Sci; 2001 Sep; 63(9):949-54. PubMed ID: 11642281
[TBL] [Abstract][Full Text] [Related]
16. Molecular biological aspects on canine and human mammary tumors.
Rivera P; von Euler H
Vet Pathol; 2011 Jan; 48(1):132-46. PubMed ID: 21147766
[TBL] [Abstract][Full Text] [Related]
17. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.
Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T
Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760
[TBL] [Abstract][Full Text] [Related]
18. Genetic variations of BRCA1 and BRCA2 genes in dogs with mammary tumours.
Enginler SO; Akış I; Toydemir TS; Oztabak K; Haktanir D; Gündüz MC; Kırşan I; Fırat I
Vet Res Commun; 2014 Mar; 38(1):21-7. PubMed ID: 24122022
[TBL] [Abstract][Full Text] [Related]
19. Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors.
Lee CH; Kim WH; Lim JH; Kang MS; Kim DY; Kweon OK
J Vet Sci; 2004 Mar; 5(1):63-9. PubMed ID: 15028887
[TBL] [Abstract][Full Text] [Related]
20. Expression patterns of the slit subfamily mRNA in canine malignant mammary tumors.
Tanno T; Tanaka Y; Sugiura T; Akiyoshi H; Takenaka S; Kuwamura M; Yamate J; Ohashi F; Kubo K; Tsuyama S
J Vet Med Sci; 2006 Nov; 68(11):1173-7. PubMed ID: 17146174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]